Rubio F, Cooley J, Accurso F J, Remold-O'Donnell E
CBR Institute for Biomedical Research Inc, Harvard Medical School, Boston, Massachusetts, USA.
Thorax. 2004 Apr;59(4):318-23. doi: 10.1136/thx.2003.014902.
In patients with cystic fibrosis (CF) neutrophils are recruited in excess to the airways yet pathogens are not cleared and the patients suffer from chronic infections. Recent studies have shown a deficiency in airway fluids from patients with CF and other inflammatory pulmonary conditions of surfactant protein A (SP-A), a pattern recognition molecule that facilitates uptake of microbes by macrophages and neutrophils.
In vitro simulations were used to test the hypothesis that decreased SP-A levels in CF might be the result of degradation by neutrophil serine proteases.
Very low levels of the neutrophil granule serine proteases cathepsin G, elastase, and proteinase-3 rapidly degraded pure SP-A when tested in buffered saline. The order of potency was cathepsin G>elastase>proteinase-3. The addition of cathepsin G or elastase to normal bronchoalveolar lavage (BAL) fluid caused a dose dependent degradation of endogenous native SP-A. Cathepsin G and elastase were present in the BAL fluid from many patients with CF. Simple incubation of protease positive BAL fluid from patients with CF caused a time dependent degradation of added SP-A or, where present, endogenous SP-A. The degradation of SP-A by protease(s) in BAL fluid of patients with CF was abrogated by diisopropylfluorophosphate and monocyte/neutrophil elastase inhibitor.
The findings strongly suggest that the neutrophil serine proteases cathepsin G and/or elastase and/or proteinase-3 contribute to degradation of SP-A and thereby diminish innate pulmonary antimicrobial defence.
在囊性纤维化(CF)患者中,中性粒细胞过度募集至气道,但病原体未被清除,患者遭受慢性感染。最近的研究表明,CF患者以及患有其他炎症性肺部疾病的患者气道分泌物中表面活性蛋白A(SP-A)缺乏,SP-A是一种模式识别分子,可促进巨噬细胞和中性粒细胞摄取微生物。
采用体外模拟试验来验证CF患者中SP-A水平降低可能是中性粒细胞丝氨酸蛋白酶降解所致这一假说。
在缓冲盐溶液中进行测试时,中性粒细胞颗粒丝氨酸蛋白酶组织蛋白酶G、弹性蛋白酶和蛋白酶-3的极低水平就能迅速降解纯SP-A。效力顺序为组织蛋白酶G>弹性蛋白酶>蛋白酶-3。向正常支气管肺泡灌洗(BAL)液中添加组织蛋白酶G或弹性蛋白酶会导致内源性天然SP-A呈剂量依赖性降解。许多CF患者的BAL液中存在组织蛋白酶G和弹性蛋白酶。CF患者蛋白酶阳性的BAL液简单孵育会导致添加的SP-A或内源性SP-A(若存在)随时间降解。CF患者BAL液中的蛋白酶对SP-A的降解可被二异丙基氟磷酸酯和单核细胞/中性粒细胞弹性蛋白酶抑制剂消除。
这些发现有力地表明,中性粒细胞丝氨酸蛋白酶组织蛋白酶G和/或弹性蛋白酶和/或蛋白酶-3促成了SP-A的降解,从而削弱了肺部先天性抗菌防御。